Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depression Treatment to Improve Antiretroviral Adherence
NCT00338767Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 2001
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoxetine in major depressive disorder (MDD), sponsored by Massachusetts General Hospital. Started Jan 2001; status: completed.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00338767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00338767.